Close Menu

NEW YORK – The US Food and Drug Administration issued finalized guidance on Tuesday for in vitro diagnostic test manufacturers designing studies for devices for CLIA waiver submissions and dual submissions for 510(k) clearance and CLIA waivers.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.